Related Experiment Video

Updated: Apr 19, 2026

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
10:43

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

20.7K

Standardizing MELD Exceptions: Current Challenges and Future Directions

David S Goldberg1, Kim M Olthoff2

  • 1Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania ; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania ; Leonard Davis Institute of Health Economics, University of Pennsylvania.

Current Transplantation Reports
|December 23, 2014
PubMed

Insights

The liver transplant waitlist uses Model for End-Stage Liver Disease (MELD) scores for organ allocation. Exception points address MELD score limitations but face challenges in standardization and evidence, requiring system improvements.

Area of Science:

  • Transplant medicine
  • Organ allocation systems
  • Medical ethics

Background:

  • The Model for End-Stage Liver Disease (MELD) score, implemented in 2002, guides liver transplant waitlist priority.
  • Exception points were introduced to accommodate patients with conditions not fully reflected by MELD.
  • The use of these exceptions has increased over time.

Purpose of the Study:

  • To summarize the current use of exception points in liver transplantation.
  • To identify and discuss challenges associated with the exception point system.
  • To propose improvements and standardization for the exception point system.

Main Methods:

  • Review of current exception point system implementation.
  • Analysis of challenges including standardization, geographic variability, and evidence base.
  • Synthesis of suggestions for system enhancement.

Main Results:

  • Exception points are increasingly utilized but face significant challenges.
  • Lack of standardization in approval criteria and geographic variability in use are prominent issues.
  • Limited evidence supports the use of certain exceptions.

Conclusions:

  • The current exception point system for liver transplant allocation requires significant reform.
  • Standardization of criteria and evidence-based practices are crucial for equitable organ distribution.
  • Addressing these challenges is vital for the integrity of the transplant waitlist.
Keywords:
MELD exceptionsregional review boardsstandardized exceptions

More Related Videos

Automated Microbial Cultivation and Adaptive Evolution using Microbial Microdroplet Culture System MMC08:18

Automated Microbial Cultivation and Adaptive Evolution using Microbial Microdroplet Culture System MMC

Published on: February 18, 2022

4.8K

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.2K
Mismatch Repair01:36

Mismatch Repair

Overview
46.1K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
227
Contaminants and Errors01:16

Contaminants and Errors

Effective sample preparation is crucial for accurate and reliable laboratory analysis. During this process, two significant sources of error can arise: concentration bias from improper sample splitting and contamination caused by methods used to reduce particle size, such as grinding or homogenization. Identifying and minimizing these potential errors is crucial to ensuring the validity of the analysis.
Another key consideration is determining the appropriate number of samples required to...
624
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
229
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
1.1K